Alzamend Neuro Inc
NASDAQ:ALZN
Alzamend Neuro Inc
NASDAQ:ALZN
Price:
1.12
USD
12%
Market Closed
Market Cap:
$4.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alzamend Neuro Inc
NASDAQ:ALZN
|
US |
|
N
|
North Asia Strategic Holdings Ltd
HKEX:8080
|
HK |
|
P
|
Playmates Holdings Ltd
HKEX:635
|
HK |
|
MLP SE
XETRA:MLP
|
DE |
|
X
|
XLMedia PLC
OTC:XLMDF
|
JE |
|
V
|
Virgin Wines UK PLC
LSE:VINO
|
UK |
|
Alpargatas SA
BOVESPA:ALPA4
|
BR |
|
K
|
Kimlun Corporation Bhd
KLSE:KIMLUN
|
MY |
|
M
|
Moiselle International Holdings Ltd
HKEX:130
|
HK |
|
C
|
Copa Corporation Inc
TSE:7689
|
JP |
|
GQG Partners Inc
ASX:GQG
|
US |
Income Statement
Earnings Waterfall
Alzamend Neuro Inc
Alzamend Neuro Inc
Income Statement
Alzamend Neuro Inc
Alzamend Neuro Inc
Currency: USD
| Apr-2021 | Jul-2021 | Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | Apr-2024 | Jul-2024 | Oct-2024 | Jan-2025 | Apr-2025 | Jul-2025 | Oct-2025 | Jan-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(5)
|
(5)
|
(8)
|
(10)
|
(12)
|
(13)
|
(13)
|
(15)
|
(15)
|
(15)
|
(15)
|
(12)
|
(10)
|
(7)
|
(6)
|
(4)
|
(4)
|
(6)
|
(6)
|
(7)
|
|
| Selling, General & Administrative |
(4)
|
(3)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(7)
|
(6)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Research & Development |
(1)
|
(1)
|
(3)
|
(4)
|
(5)
|
(6)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(8)
|
(6)
|
(4)
|
(3)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
|
| Operating Income |
(5)
N/A
|
(5)
+7%
|
(8)
-78%
|
(10)
-19%
|
(12)
-27%
|
(13)
-6%
|
(13)
+4%
|
(15)
-23%
|
(15)
+4%
|
(15)
-3%
|
(15)
+1%
|
(12)
+18%
|
(10)
+20%
|
(7)
+26%
|
(6)
+21%
|
(4)
+28%
|
(4)
-7%
|
(6)
-39%
|
(6)
+6%
|
(7)
-20%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(5)
N/A
|
(5)
+7%
|
(8)
-77%
|
(10)
-17%
|
(12)
-27%
|
(13)
-6%
|
(13)
+4%
|
(15)
-23%
|
(15)
+4%
|
(15)
-3%
|
(15)
+1%
|
(12)
+18%
|
(10)
+20%
|
(7)
+26%
|
(6)
+21%
|
(4)
+28%
|
(5)
-7%
|
(6)
-38%
|
(6)
+6%
|
(7)
-20%
|
|
| Net Income | |||||||||||||||||||||
| Income from Continuing Operations |
(5)
|
(5)
|
(8)
|
(10)
|
(12)
|
(13)
|
(13)
|
(15)
|
(15)
|
(15)
|
(15)
|
(12)
|
(10)
|
(7)
|
(6)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
+7%
|
(8)
-77%
|
(10)
-17%
|
(12)
-27%
|
(13)
-6%
|
(13)
+4%
|
(15)
-23%
|
(15)
+4%
|
(15)
-3%
|
(15)
+1%
|
(12)
+18%
|
(10)
+20%
|
(7)
+26%
|
(6)
+20%
|
(4)
+27%
|
(5)
-19%
|
(7)
-35%
|
(6)
+6%
|
(8)
-18%
|
|
| EPS (Diluted) |
-80.27
N/A
|
-75
+7%
|
-119.89
-60%
|
-139.78
-17%
|
-187.27
-34%
|
-181.13
+3%
|
-174.32
+4%
|
-212.1
-22%
|
-205.98
+3%
|
-210.91
-2%
|
-208.09
+1%
|
-158.31
+24%
|
-132.33
+16%
|
-85.56
+35%
|
-15.04
+82%
|
-6.98
+54%
|
-11.32
-62%
|
-3.27
+71%
|
-1.91
+42%
|
-2
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
